Guardian Pharmacy (GRDN) Services announced the launch of a proposed underwritten public offering of 7.5M shares of its Class A common stock, consisting of 6.06M shares being offered by certain selling stockholders and 1.44M newly issued shares being offered by Guardian as part of a non-dilutive “synthetic secondary” transaction. Guardian will not receive any proceeds from the offering of shares by the selling stockholders in the offering. Raymond James is acting as lead bookrunning manager of the offering and as representative of the underwriters for the proposed offering. Stephens Inc. and Truist Securities are acting as joint bookrunning managers for the offering.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRDN:
- Guardian Pharmacy files to sell 1.44M shares of Class A common stock
- Guardian Pharmacy files to sell 6.06M shares of Class A common stock for holders
- Guardian Pharmacy price target raised to $28 from $25 at Truist
- Guardian Pharmacy announces acquisition of Senior Care Pharmacy in Wichita
- Guardian Pharmacy price target raised to $28 from $25 at Raymond James
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue